Trade TRAX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
First Tracks Biotherapeutics, Inc. (TRAX) is trading at US$33.28, down 1.89% today as of Oct 2, 16:00 EDT. The company has a market capitalisation of US$1.54B. Over the past 52 weeks, TRAX has traded between US$14.72 and US$49.91. On Syfe you can trade TRAX with $0 commission and add it to your watchlist.
| Previous close | US$33.92 |
|---|---|
| Market cap | US$1.54B |
| 52-week range | US$14.72 – US$49.91 |
| Volume | 1.17M |
| Exchange | US |
First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
Year: 2026
Wedbush Adjusts PT on First Tracks Biotherapeutics to $70 From $60, Maintains Outperform Rating
Aug 13, 10:51 AM · MT Newswires
UBS Adjusts First Tracks Biotherapeutics PT to $65 From $45, Maintains Buy Rating
Aug 10, 1:29 PM · MT Newswires
First Tracks Biotherapeutics, Inc. (TRAX) stock is trading at US$33.28, -1.89% from the previous close of US$33.92.
The market cap for First Tracks Biotherapeutics, Inc. (TRAX) stock is approximately US$1.54B.
The 52-week high for First Tracks Biotherapeutics, Inc. (TRAX) stock is US$49.91.
The 52-week low for First Tracks Biotherapeutics, Inc. (TRAX) stock is US$14.72.
First Tracks Biotherapeutics, Inc. (TRAX) does not currently pay a dividend.
Stay on top of TRAX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
